Jagsonpal Pharmaceuticals Announcements
Allotment of 1,76,900 Equity Shares under Jagsonpal Pharmaceuticals Limited Employee Stock Option, Plan 2022
13 Apr, 2026 | 04:26pm • Source: BSE
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026
10 Apr, 2026 | 04:52pm • Source: BSE
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby submit copy of advertisement published in Newspaper with regard to Postal Ballot Notice sent...
26 Mar, 2026 | 04:48pm • Source: BSE
Closure of Trading Window for the quarter and Financial Year Ended on March 31, 2026.
26 Mar, 2026 | 04:37pm • Source: BSE
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015, Please find attached Postal ballot Notice relating to approval for Buy back of upto Rs. 16,00,000...
25 Mar, 2026 | 04:56pm • Source: BSE
Please release on announcement of buy back of Equity shares of Company
12 Mar, 2026 | 02:30pm • Source: BSE
Please find attached outcome of meeting held on March 12, 2026 for consideration of buy back of equity shares.
12 Mar, 2026 | 01:57pm • Source: BSE
Intimation for grant of Employee stock options
09 Mar, 2026 | 03:41pm • Source: BSE
Earnings Call Transcript for meeting held on 22 January, 2026
27 Jan, 2026 | 03:12pm • Source: BSE
In continuation to our earlier intimation dated January 15, 2026, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and...
22 Jan, 2026 | 06:55pm • Source: BSE
Pursuant to Regulation 47 of SEBI (LODR), 2015, please find enclosed copies of advertisement published on January 22, 2026 in Business Standard (English) and Business...
22 Jan, 2026 | 09:37am • Source: BSE
Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2026 ,inter alia, to consider and...
13 Jan, 2026 | 04:25pm • Source: BSE
Pursuant to Regulation 74(5) of SEBI (DP)Regulations, 2018 we are enclosing herewith a copy of the Certificate, received from MCS Share Transfer agent limited, the...
06 Jan, 2026 | 05:13pm • Source: BSE
Allotment of 1,09,180 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022
06 Jan, 2026 | 05:02pm • Source: BSE
Pursuant to provisions of Regulation 30 of SEBI (LODR), 2015, we hereby submit the disclosure regarding the order received from authority.
30 Dec, 2025 | 04:51pm • Source: BSE
Pursuant to SEBI (PIT) Regulations, 2015, the trading window for dealing in securities of Company shall remain closed from January 01, 2026 till 48...
26 Dec, 2025 | 12:54pm • Source: BSE
Jagsonpal Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
05 Dec, 2025 | 03:13pm • Source: NSE
Please find enclosed herewith copies of newspaper advertisement published on December 05, 2025 informing shareholders regarding opening of special window for Re-lodgement of transfer request...
05 Dec, 2025 | 03:04pm • Source: BSE
Allotment of 56,571 Equity Shares under the Jagsonpal Pharmaceuticals Limited employee stock option plan 2022.
18 Nov, 2025 | 11:39am • Source: BSE
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, Please find enclosed transcript for the jagsonpal pharmaceuticals Limited Q2 FY 2026 earnings call held on...
07 Nov, 2025 | 03:16pm • Source: BSE